Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Neglected Tropical Diseases Diagnosis
... reach US$10.3 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Conventional Method, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach ... Read More
-
Acute Repetitive Seizures
... by 2030, growing at a CAGR of 44.7% over the analysis period 2023-2030. Diastat Rectal Gel, one of the segments analyzed in the report, is expected to record a 46.2% CAGR and reach US$8.4 Billion ... Read More
-
Lou Gehrig’s disease - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Myotonic Dystrophy - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Type 2 Diabetes - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Neuroprotection Therapeutics
... at a CAGR of 6.9% over the analysis period 2023-2030. Free Radical Trapping Agents (Antioxidants), one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$45.7 Billion by ... Read More
-
Cutaneous T-cell lymphoma - Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Sarcoma Drugs
... at a CAGR of 7.5% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.9 Billion by the end of ... Read More
-
Glioblastoma Multiforme Treatment (GBM)
... reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Radiation Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More
-
Guillain-Barre Syndrome Therapeutics
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Intravenous Immunoglobulin Therapeutics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$541.2 Million ... Read More
-
Myasthenia Gravis Treatment
... by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Medication Treatment, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$2.2 Billion by ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Therapeutics
... the year 2023, is expected to reach US$54.0 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to ... Read More
-
Degenerative Disc Disease Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... market size was valued at USD 26.05 billion in 2021, and the market is now projected to grow from USD 27.87 billion in 2022 to USD 45.92 billion by 2029, exhibiting a CAGR of 7.4% ... Read More
-
Urothelial Cancer Drugs
... by 2030, growing at a CAGR of 20.6% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$13.3 Billion by the ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Chlamydia Infection Diagnostics, one of the segments analyzed in the report, is expected to record a ... Read More
-
Fragment-based Drug Discovery
... by 2030, growing at a CAGR of 8.8% over the analysis period 2023-2030. Fragment Screening, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$1.1 Billion by ... Read More
-
Liver Diseases Treatment
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. Anti-Rejection Drugs/Immunosupressants Treatment, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$6.3 Billion ... Read More
-
Artificial Intelligence (AI) in Drug Discovery
... the year 2023, is expected to reach US$13.5 Billion by 2030, growing at a CAGR of 26.4% over the analysis period 2023-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected ... Read More
-
Radiodermatitis
... of 4.2% over the analysis period 2023-2030. Topical Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$412.0 Million by the end of the analysis period. ... Read More
-
Rapid Application Development
... by 2030, growing at a CAGR of 37.6% over the analysis period 2023-2030. Tools Component, one of the segments analyzed in the report, is expected to record a 36.1% CAGR and reach US$465.3 Billion by ... Read More
-
Influenza Medication
... at a CAGR of 1.9% over the analysis period 2023-2030. Zanamivir, one of the segments analyzed in the report, is expected to record a 1.2% CAGR and reach US$123.9 Million by the end of the ... Read More
-
Osteoarthritis Therapeutics
... at a CAGR of 7.2% over the analysis period 2023-2030. Knee Anatomy, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$7.1 Billion by the end of ... Read More
-
Smoking Cessation- Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Smoking ... Read More
-
Lupus Nephritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global protein therapeutics market by segmenting the market based on ... Read More
Research Assistance
